Global Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Region: Trend Forecast and Growth Opportunity
Global clinical trials market will reach $79,977.1 million by 2031, growing by 7.0% annually over 2022-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.
Highlighted with 148 tables and 111 figures, this 241-page report “Global Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Based on Product Category, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
Phlexglobal
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Highlighted with 148 tables and 111 figures, this 241-page report “Global Clinical Trials Market 2022-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2031 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
Based on Product Category, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.
- Trials of Drugs
- Small Molecule Drugs
- Vaccines
- Cell & Gene Therapy
- Other Drugs
- Trials of Devices
- Trials of Procedures
- Phase I
- Phase II
- Phase III
- Phase IV
- Interventional Studies
- Randomized Control Trial
- Adaptive Clinical Trial
- Non-randomized Control Trial
- Observational Studies
- Cohort Study
- Case Control Study
- Cross Sectional Study
- Ecological Study
- Expanded Access Trials
- Protocol Designing
- Site Identification
- Patient Recruitment
- Laboratory Services
- Bioanalytical Testing Services
- Clinical Trial Data Management Services
- Clinical Trial Supply & Logistic Services
- Decentralized Clinical Trial Services
- Medical Device Testing Services
- Other Clinical Trial Services
- Oncology
- Infectious Diseases
- Cardiology
- Obesity
- Diabetes
- Neurology
- Immunology
- Pain Management
- Other Indications
- Pharmaceutical and Biotechnological Companies
- Clinical Research Organizations
- Clinical Testing Laboratories
- Other End Users
- North America (U.S., Canada, and Mexico)
- Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
- APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
- South America (Brazil, Chile, Argentina, Rest of South America)
- MEA (UAE, Saudi Arabia, South Africa and Rest of MEA)
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
Phlexglobal
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT CATEGORY
3.1 Market Overview by Product Category
3.2 Trials of Drugs
3.2.1 Small Molecule Drugs
3.2.2 Vaccines
3.2.3 Cell & Gene Therapy
3.2.4 Other Drugs
3.3 Trials of Devices
3.4 Trials of Procedures
4 SEGMENTATION OF GLOBAL MARKET BY PHASE
4.1 Market Overview by Phase
4.2 Phase I
4.3 Phase II
4.4 Phase III
4.5 Phase IV
5 SEGMENTATION OF GLOBAL MARKET BY DESIGN
5.1 Market Overview by Design
5.2 Interventional Studies
5.2.1 Randomized Control Trial
5.2.2 Adaptive Clinical Trial
5.2.3 Non-randomized Control Trial
5.3 Observational Studies
5.3.1 Cohort Study
5.3.2 Case Control Study
5.3.3 Cross Sectional Study
5.3.4 Ecological Study
5.4 Expanded Access Trials
6 SEGMENTATION OF GLOBAL MARKET BY SERVICE TYPE
6.1 Market Overview by Service Type
6.2 Protocol Designing
6.3 Site Identification
6.4 Patient Recruitment
6.5 Laboratory Services
6.6 Bioanalytical Testing Services
6.7 Clinical Trial Data Management Services
6.8 Clinical Trial Supply & Logistic Services
6.9 Decentralized Clinical Trial Services
6.10 Medical Device Testing Services
6.11 Other Clinical Trial Services
7 SEGMENTATION OF GLOBAL MARKET BY INDICATION
7.1 Market Overview by Indication
7.2 Oncology
7.3 Infectious Diseases
7.4 Cardiology
7.5 Obesity
7.6 Diabetes
7.7 Neurology
7.8 Immunology
7.9 Pain Management
7.10 Other Indications
8 SEGMENTATION OF GLOBAL MARKET BY END USER
8.1 Market Overview by End User
8.2 Pharmaceutical and Biotechnological Companies
8.3 Clinical Research Organizations
8.4 Clinical Testing Laboratories
8.5 Other End Users
9 SEGMENTATION OF GLOBAL MARKET BY REGION
9.1 Geographic Market Overview 2021-2031
9.2 North America Market 2021-2031 by Country
9.2.1 Overview of North America Market
9.2.2 U.S.
9.2.3 Canada
9.2.4 Mexico
9.3 European Market 2021-2031 by Country
9.3.1 Overview of European Market
9.3.2 Germany
9.3.3 U.K.
9.3.4 France
9.3.5 Spain
9.3.6 Italy
9.3.7 Russia
9.3.8 Rest of European Market
9.4 Asia-Pacific Market 2021-2031 by Country
9.4.1 Overview of Asia-Pacific Market
9.4.2 Japan
9.4.3 China
9.4.4 Australia
9.4.5 India
9.4.6 South Korea
9.4.7 Rest of APAC Region
9.5 South America Market 2021-2031 by Country
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America Market
9.6 MEA Market 2021-2031 by Country
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 Other National Markets
10 COMPETITIVE LANDSCAPE
10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
Phlexglobal
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc.
RELATED REPORTS
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT CATEGORY
3.1 Market Overview by Product Category
3.2 Trials of Drugs
3.2.1 Small Molecule Drugs
3.2.2 Vaccines
3.2.3 Cell & Gene Therapy
3.2.4 Other Drugs
3.3 Trials of Devices
3.4 Trials of Procedures
4 SEGMENTATION OF GLOBAL MARKET BY PHASE
4.1 Market Overview by Phase
4.2 Phase I
4.3 Phase II
4.4 Phase III
4.5 Phase IV
5 SEGMENTATION OF GLOBAL MARKET BY DESIGN
5.1 Market Overview by Design
5.2 Interventional Studies
5.2.1 Randomized Control Trial
5.2.2 Adaptive Clinical Trial
5.2.3 Non-randomized Control Trial
5.3 Observational Studies
5.3.1 Cohort Study
5.3.2 Case Control Study
5.3.3 Cross Sectional Study
5.3.4 Ecological Study
5.4 Expanded Access Trials
6 SEGMENTATION OF GLOBAL MARKET BY SERVICE TYPE
6.1 Market Overview by Service Type
6.2 Protocol Designing
6.3 Site Identification
6.4 Patient Recruitment
6.5 Laboratory Services
6.6 Bioanalytical Testing Services
6.7 Clinical Trial Data Management Services
6.8 Clinical Trial Supply & Logistic Services
6.9 Decentralized Clinical Trial Services
6.10 Medical Device Testing Services
6.11 Other Clinical Trial Services
7 SEGMENTATION OF GLOBAL MARKET BY INDICATION
7.1 Market Overview by Indication
7.2 Oncology
7.3 Infectious Diseases
7.4 Cardiology
7.5 Obesity
7.6 Diabetes
7.7 Neurology
7.8 Immunology
7.9 Pain Management
7.10 Other Indications
8 SEGMENTATION OF GLOBAL MARKET BY END USER
8.1 Market Overview by End User
8.2 Pharmaceutical and Biotechnological Companies
8.3 Clinical Research Organizations
8.4 Clinical Testing Laboratories
8.5 Other End Users
9 SEGMENTATION OF GLOBAL MARKET BY REGION
9.1 Geographic Market Overview 2021-2031
9.2 North America Market 2021-2031 by Country
9.2.1 Overview of North America Market
9.2.2 U.S.
9.2.3 Canada
9.2.4 Mexico
9.3 European Market 2021-2031 by Country
9.3.1 Overview of European Market
9.3.2 Germany
9.3.3 U.K.
9.3.4 France
9.3.5 Spain
9.3.6 Italy
9.3.7 Russia
9.3.8 Rest of European Market
9.4 Asia-Pacific Market 2021-2031 by Country
9.4.1 Overview of Asia-Pacific Market
9.4.2 Japan
9.4.3 China
9.4.4 Australia
9.4.5 India
9.4.6 South Korea
9.4.7 Rest of APAC Region
9.5 South America Market 2021-2031 by Country
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America Market
9.6 MEA Market 2021-2031 by Country
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 South Africa
9.6.4 Other National Markets
10 COMPETITIVE LANDSCAPE
10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Accell Clinical Research LLC
Charles River Laboratories
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America (Covance Inc.)
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
Phlexglobal
PRA Health Sciences
Sanofi SA
SGS SA (SGS Life Sciences)
Syneos Health Inc.
Wuxi AppTec Inc.
RELATED REPORTS
LIST OF TABLES:
Table 1. Snapshot of Global Clinical Trials Market in Balanced Perspective, 2022-2031
Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-2021
Table 3. World Economic Outlook, 2021-2031
Table 4. World Economic Outlook, 2021-2023
Table 5. Scenarios for Economic Impact of Ukraine Crisis
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in Global Clinical Trials Market
Table 8. Global Clinical Trials Market by Product Category, 2021-2031, $ mn
Table 9. Global Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, $ mn
Table 10. Global Clinical Trials Market by Phase, 2021-2031, $ mn
Table 11. Global Clinical Trials Market by Design, 2021-2031, $ mn
Table 12. Global Clinical Trials Market: Interventional Studies by Segment, 2021-2031, $ mn
Table 13. Global Clinical Trials Market: Observational Studies by Segment, 2021-2031, $ mn
Table 14. Global Clinical Trials Market by Service Type, 2021-2031, $ mn
Table 15. Global Clinical Trials Market by Indication, 2021-2031, $ mn
Table 16. Global Clinical Trials Market by End User, 2021-2031, $ mn
Table 17. Global Clinical Trials Market by Region, 2021-2031, $ mn
Table 18. Leading National Clinical Trials Market, 2022 and 2031, $ mn
Table 19. North America Clinical Trials Market by Country, 2021-2031, $ mn
Table 20. U.S. Clinical Trials Market by Phase, 2021-2031, $ mn
Table 21. U.S. Clinical Trials Market by Design, 2021-2031, $ mn
Table 22. U.S. Clinical Trials Market by Indication, 2021-2031, $ mn
Table 23. Canada Clinical Trials Market by Phase, 2021-2031, $ mn
Table 24. Canada Clinical Trials Market by Design, 2021-2031, $ mn
Table 25. Canada Clinical Trials Market by Indication, 2021-2031, $ mn
Table 26. Mexico Clinical Trials Market by Phase, 2021-2031, $ mn
Table 27. Mexico Clinical Trials Market by Design, 2021-2031, $ mn
Table 28. Mexico Clinical Trials Market by Indication, 2021-2031, $ mn
Table 29. Europe Clinical Trials Market by Country, 2021-2031, $ mn
Table 30. Germany Clinical Trials Market by Phase, 2021-2031, $ mn
Table 31. Germany Clinical Trials Market by Design, 2021-2031, $ mn
Table 32. Germany Clinical Trials Market by Indication, 2021-2031, $ mn
Table 33. U.K. Clinical Trials Market by Phase, 2021-2031, $ mn
Table 34. U.K. Clinical Trials Market by Design, 2021-2031, $ mn
Table 35. U.K. Clinical Trials Market by Indication, 2021-2031, $ mn
Table 36. France Clinical Trials Market by Phase, 2021-2031, $ mn
Table 37. France Clinical Trials Market by Design, 2021-2031, $ mn
Table 38. France Clinical Trials Market by Indication, 2021-2031, $ mn
Table 39. Spain Clinical Trials Market by Phase, 2021-2031, $ mn
Table 40. Spain Clinical Trials Market by Design, 2021-2031, $ mn
Table 41. Spain Clinical Trials Market by Indication, 2021-2031, $ mn
Table 42. Italy Clinical Trials Market by Phase, 2021-2031, $ mn
Table 43. Italy Clinical Trials Market by Design, 2021-2031, $ mn
Table 44. Italy Clinical Trials Market by Indication, 2021-2031, $ mn
Table 45. Russia Clinical Trials Market by Phase, 2021-2031, $ mn
Table 46. Russia Clinical Trials Market by Design, 2021-2031, $ mn
Table 47. Russia Clinical Trials Market by Indication, 2021-2031, $ mn
Table 48. Clinical Trials Market in Rest of Europe by Country, 2021-2031, $ mn
Table 49. APAC Clinical Trials Market by Country, 2021-2031, $ mn
Table 50. Japan Clinical Trials Market by Phase, 2021-2031, $ mn
Table 51. Japan Clinical Trials Market by Design, 2021-2031, $ mn
Table 52. Japan Clinical Trials Market by Indication, 2021-2031, $ mn
Table 53. China Clinical Trials Market by Phase, 2021-2031, $ mn
Table 54. China Clinical Trials Market by Design, 2021-2031, $ mn
Table 55. China Clinical Trials Market by Indication, 2021-2031, $ mn
Table 56. Australia Clinical Trials Market by Phase, 2021-2031, $ mn
Table 57. Australia Clinical Trials Market by Design, 2021-2031, $ mn
Table 58. Australia Clinical Trials Market by Indication, 2021-2031, $ mn
Table 59. India Clinical Trials Market by Phase, 2021-2031, $ mn
Table 60. India Clinical Trials Market by Design, 2021-2031, $ mn
Table 61. India Clinical Trials Market by Indication, 2021-2031, $ mn
Table 62. South Korea Clinical Trials Market by Phase, 2021-2031, $ mn
Table 63. South Korea Clinical Trials Market by Design, 2021-2031, $ mn
Table 64. South Korea Clinical Trials Market by Indication, 2021-2031, $ mn
Table 65. Clinical Trials Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 66. South America Clinical Trials Market by Country, 2021-2031, $ mn
Table 67. Argentina Clinical Trials Market by Phase, 2021-2031, $ mn
Table 68. Argentina Clinical Trials Market by Design, 2021-2031, $ mn
Table 69. Argentina Clinical Trials Market by Indication, 2021-2031, $ mn
Table 70. Brazil Clinical Trials Market by Phase, 2021-2031, $ mn
Table 71. Brazil Clinical Trials Market by Design, 2021-2031, $ mn
Table 72. Brazil Clinical Trials Market by Indication, 2021-2031, $ mn
Table 73. Chile Clinical Trials Market by Phase, 2021-2031, $ mn
Table 74. Chile Clinical Trials Market by Design, 2021-2031, $ mn
Table 75. Chile Clinical Trials Market by Indication, 2021-2031, $ mn
Table 76. MEA Clinical Trials Market by Country, 2021-2031, $ mn
Table 77. UAE Clinical Trials Market by Phase, 2021-2031, $ mn
Table 78. UAE Clinical Trials Market by Design, 2021-2031, $ mn
Table 79. UAE Clinical Trials Market by Indication, 2021-2031, $ mn
Table 80. Saudi Arabia Clinical Trials Market by Phase, 2021-2031, $ mn
Table 81. Saudi Arabia Clinical Trials Market by Design, 2021-2031, $ mn
Table 82. Saudi Arabia Clinical Trials Market by Indication, 2021-2031, $ mn
Table 83. South Africa Clinical Trials Market by Phase, 2021-2031, $ mn
Table 84. South Africa Clinical Trials Market by Design, 2021-2031, $ mn
Table 85. South Africa Clinical Trials Market by Indication, 2021-2031, $ mn
Table 86. Percentage of Registered Studies by Location (as of February 24, 2022)
Table 87. Percentage of Recruiting Studies by Location (as of February 24, 2022)
Table 88. Accell Clinical Research LLC: Company Snapshot
Table 89. Accell Clinical Research LLC: Business Segmentation
Table 90. Accell Clinical Research LLC: Product Portfolio
Table 91. Charles River Laboratories: Company Snapshot
Table 92. Charles River Laboratories: Product Portfolio
Table 93. Charles River Laboratories: Breakdown of Revenue by Division
Table 94. Charles River Laboratories: Breakdown of Revenue by Region
Table 95. ClinDatrix Inc: Company Snapshot
Table 96. Clinipace: Company Snapshot
Table 97. Clinipace: Product Portfolio
Table 98. Eli Lilly and Company: Company Snapshot
Table 99. Eli Lilly and Company: Pharmaceutical Brands
Table 100. Eli Lilly and Company: Clinical Trial Service
Table 101. Eli Lilly and Company: Breakdown of Revenue by Therapeutic Area
Table 102. Eli Lilly and Company: Breakdown of Revenue by Region
Table 103. F. Hoffmann-La Roche: Company Snapshot
Table 104. F. Hoffmann-La Roche: Clinical Trial Service
Table 105. F. Hoffmann-La Roche: Business Segmentation
Table 106. F. Hoffmann-La Roche: Revenue by Region
Table 107. ICON Plc: Company Snapshot
Table 108. ICON Plc: Business Segmentation
Table 109. ICON Plc: Product Portfolio
Table 110. ICON Plc: Revenue by Region, 2020, %
Table 111. IQVIA Holdings Inc.: Company Snapshot
Table 112. IQVIA Holdings Inc.: Business Segmentation
Table 113. IQVIA Holdings Inc.: Revenue by Region, 2020, %
Table 114. IQVIA Holdings Inc.: Product Portfolio
Table 115. Covance Inc.: Company Snapshot
Table 116. Covance Inc.: Product Portfolio
Table 117. Covance Inc.: Revenue by Region, 2020, %
Table 118. Novo Nordisk: Company Snapshot
Table 119. Novo Nordisk: Product Portfolio
Table 120. Novo Nordisk: Breakdown of Revenue by Business Segment
Table 121. Novo Nordisk: Breakdown of Revenue by Region
Table 122. PAREXEL International Corporation: Company Snapshot
Table 123. PAREXEL International Corporation: Business Segmentation
Table 124. PAREXEL International Corporation: Revenue by Region, 2018, %
Table 125. PAREXEL International Corporation: Product Portfolio
Table 126. Pfizer Inc.: Company Snapshot
Table 127. Pfizer Inc.: Business Segmentation
Table 128. Pfizer Inc.: Breakdown of Revenue by Product Category
Table 129. Pfizer Inc.: Breakdown of Revenue by Region
Table 130. Pfizer Inc.: Product Portfolio
Table 131. Pfizer Inc.: Revenue, 2018-2020, $ bn
Table 132. Pharmaceutical Product Development LLC (PPD): Company Snapshot
Table 133. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Division
Table 134. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Region
Table 135. Phlexglobal: Company Snapshot
Table 136. PRA Health Sciences Inc.: Company Snapshot
Table 137. PRA Health Sciences Inc.: Business Segmentation
Table 138. PRA Health Sciences Inc.: Revenue by Region, 2018, %
Table 139. Sanofi: Company Snapshot
Table 140. Sanofi: Business Segmentation
Table 141. Sanofi: Breakdown of Revenue by Region
Table 142. SGS SA (SGS Life Sciences): Company Snapshot
Table 143. SGS SA (SGS Life Sciences): Business Segmentation
Table 144. SGS SA (SGS Life Sciences): Revenue by Region, 2018, %
Table 145. Syneos Health Inc.: Company Snapshot
Table 146. Syneos Health Inc.: Business Segmentation
Table 147. Syneos Health Inc.: Revenue by Region, 2020, %
Table 148. WuXi AppTec Inc.: Company Snapshot
Table 1. Snapshot of Global Clinical Trials Market in Balanced Perspective, 2022-2031
Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-2021
Table 3. World Economic Outlook, 2021-2031
Table 4. World Economic Outlook, 2021-2023
Table 5. Scenarios for Economic Impact of Ukraine Crisis
Table 6. World Health Spending by Region, $ bn, 2013-2020
Table 7. Main Product Trends and Market Opportunities in Global Clinical Trials Market
Table 8. Global Clinical Trials Market by Product Category, 2021-2031, $ mn
Table 9. Global Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, $ mn
Table 10. Global Clinical Trials Market by Phase, 2021-2031, $ mn
Table 11. Global Clinical Trials Market by Design, 2021-2031, $ mn
Table 12. Global Clinical Trials Market: Interventional Studies by Segment, 2021-2031, $ mn
Table 13. Global Clinical Trials Market: Observational Studies by Segment, 2021-2031, $ mn
Table 14. Global Clinical Trials Market by Service Type, 2021-2031, $ mn
Table 15. Global Clinical Trials Market by Indication, 2021-2031, $ mn
Table 16. Global Clinical Trials Market by End User, 2021-2031, $ mn
Table 17. Global Clinical Trials Market by Region, 2021-2031, $ mn
Table 18. Leading National Clinical Trials Market, 2022 and 2031, $ mn
Table 19. North America Clinical Trials Market by Country, 2021-2031, $ mn
Table 20. U.S. Clinical Trials Market by Phase, 2021-2031, $ mn
Table 21. U.S. Clinical Trials Market by Design, 2021-2031, $ mn
Table 22. U.S. Clinical Trials Market by Indication, 2021-2031, $ mn
Table 23. Canada Clinical Trials Market by Phase, 2021-2031, $ mn
Table 24. Canada Clinical Trials Market by Design, 2021-2031, $ mn
Table 25. Canada Clinical Trials Market by Indication, 2021-2031, $ mn
Table 26. Mexico Clinical Trials Market by Phase, 2021-2031, $ mn
Table 27. Mexico Clinical Trials Market by Design, 2021-2031, $ mn
Table 28. Mexico Clinical Trials Market by Indication, 2021-2031, $ mn
Table 29. Europe Clinical Trials Market by Country, 2021-2031, $ mn
Table 30. Germany Clinical Trials Market by Phase, 2021-2031, $ mn
Table 31. Germany Clinical Trials Market by Design, 2021-2031, $ mn
Table 32. Germany Clinical Trials Market by Indication, 2021-2031, $ mn
Table 33. U.K. Clinical Trials Market by Phase, 2021-2031, $ mn
Table 34. U.K. Clinical Trials Market by Design, 2021-2031, $ mn
Table 35. U.K. Clinical Trials Market by Indication, 2021-2031, $ mn
Table 36. France Clinical Trials Market by Phase, 2021-2031, $ mn
Table 37. France Clinical Trials Market by Design, 2021-2031, $ mn
Table 38. France Clinical Trials Market by Indication, 2021-2031, $ mn
Table 39. Spain Clinical Trials Market by Phase, 2021-2031, $ mn
Table 40. Spain Clinical Trials Market by Design, 2021-2031, $ mn
Table 41. Spain Clinical Trials Market by Indication, 2021-2031, $ mn
Table 42. Italy Clinical Trials Market by Phase, 2021-2031, $ mn
Table 43. Italy Clinical Trials Market by Design, 2021-2031, $ mn
Table 44. Italy Clinical Trials Market by Indication, 2021-2031, $ mn
Table 45. Russia Clinical Trials Market by Phase, 2021-2031, $ mn
Table 46. Russia Clinical Trials Market by Design, 2021-2031, $ mn
Table 47. Russia Clinical Trials Market by Indication, 2021-2031, $ mn
Table 48. Clinical Trials Market in Rest of Europe by Country, 2021-2031, $ mn
Table 49. APAC Clinical Trials Market by Country, 2021-2031, $ mn
Table 50. Japan Clinical Trials Market by Phase, 2021-2031, $ mn
Table 51. Japan Clinical Trials Market by Design, 2021-2031, $ mn
Table 52. Japan Clinical Trials Market by Indication, 2021-2031, $ mn
Table 53. China Clinical Trials Market by Phase, 2021-2031, $ mn
Table 54. China Clinical Trials Market by Design, 2021-2031, $ mn
Table 55. China Clinical Trials Market by Indication, 2021-2031, $ mn
Table 56. Australia Clinical Trials Market by Phase, 2021-2031, $ mn
Table 57. Australia Clinical Trials Market by Design, 2021-2031, $ mn
Table 58. Australia Clinical Trials Market by Indication, 2021-2031, $ mn
Table 59. India Clinical Trials Market by Phase, 2021-2031, $ mn
Table 60. India Clinical Trials Market by Design, 2021-2031, $ mn
Table 61. India Clinical Trials Market by Indication, 2021-2031, $ mn
Table 62. South Korea Clinical Trials Market by Phase, 2021-2031, $ mn
Table 63. South Korea Clinical Trials Market by Design, 2021-2031, $ mn
Table 64. South Korea Clinical Trials Market by Indication, 2021-2031, $ mn
Table 65. Clinical Trials Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 66. South America Clinical Trials Market by Country, 2021-2031, $ mn
Table 67. Argentina Clinical Trials Market by Phase, 2021-2031, $ mn
Table 68. Argentina Clinical Trials Market by Design, 2021-2031, $ mn
Table 69. Argentina Clinical Trials Market by Indication, 2021-2031, $ mn
Table 70. Brazil Clinical Trials Market by Phase, 2021-2031, $ mn
Table 71. Brazil Clinical Trials Market by Design, 2021-2031, $ mn
Table 72. Brazil Clinical Trials Market by Indication, 2021-2031, $ mn
Table 73. Chile Clinical Trials Market by Phase, 2021-2031, $ mn
Table 74. Chile Clinical Trials Market by Design, 2021-2031, $ mn
Table 75. Chile Clinical Trials Market by Indication, 2021-2031, $ mn
Table 76. MEA Clinical Trials Market by Country, 2021-2031, $ mn
Table 77. UAE Clinical Trials Market by Phase, 2021-2031, $ mn
Table 78. UAE Clinical Trials Market by Design, 2021-2031, $ mn
Table 79. UAE Clinical Trials Market by Indication, 2021-2031, $ mn
Table 80. Saudi Arabia Clinical Trials Market by Phase, 2021-2031, $ mn
Table 81. Saudi Arabia Clinical Trials Market by Design, 2021-2031, $ mn
Table 82. Saudi Arabia Clinical Trials Market by Indication, 2021-2031, $ mn
Table 83. South Africa Clinical Trials Market by Phase, 2021-2031, $ mn
Table 84. South Africa Clinical Trials Market by Design, 2021-2031, $ mn
Table 85. South Africa Clinical Trials Market by Indication, 2021-2031, $ mn
Table 86. Percentage of Registered Studies by Location (as of February 24, 2022)
Table 87. Percentage of Recruiting Studies by Location (as of February 24, 2022)
Table 88. Accell Clinical Research LLC: Company Snapshot
Table 89. Accell Clinical Research LLC: Business Segmentation
Table 90. Accell Clinical Research LLC: Product Portfolio
Table 91. Charles River Laboratories: Company Snapshot
Table 92. Charles River Laboratories: Product Portfolio
Table 93. Charles River Laboratories: Breakdown of Revenue by Division
Table 94. Charles River Laboratories: Breakdown of Revenue by Region
Table 95. ClinDatrix Inc: Company Snapshot
Table 96. Clinipace: Company Snapshot
Table 97. Clinipace: Product Portfolio
Table 98. Eli Lilly and Company: Company Snapshot
Table 99. Eli Lilly and Company: Pharmaceutical Brands
Table 100. Eli Lilly and Company: Clinical Trial Service
Table 101. Eli Lilly and Company: Breakdown of Revenue by Therapeutic Area
Table 102. Eli Lilly and Company: Breakdown of Revenue by Region
Table 103. F. Hoffmann-La Roche: Company Snapshot
Table 104. F. Hoffmann-La Roche: Clinical Trial Service
Table 105. F. Hoffmann-La Roche: Business Segmentation
Table 106. F. Hoffmann-La Roche: Revenue by Region
Table 107. ICON Plc: Company Snapshot
Table 108. ICON Plc: Business Segmentation
Table 109. ICON Plc: Product Portfolio
Table 110. ICON Plc: Revenue by Region, 2020, %
Table 111. IQVIA Holdings Inc.: Company Snapshot
Table 112. IQVIA Holdings Inc.: Business Segmentation
Table 113. IQVIA Holdings Inc.: Revenue by Region, 2020, %
Table 114. IQVIA Holdings Inc.: Product Portfolio
Table 115. Covance Inc.: Company Snapshot
Table 116. Covance Inc.: Product Portfolio
Table 117. Covance Inc.: Revenue by Region, 2020, %
Table 118. Novo Nordisk: Company Snapshot
Table 119. Novo Nordisk: Product Portfolio
Table 120. Novo Nordisk: Breakdown of Revenue by Business Segment
Table 121. Novo Nordisk: Breakdown of Revenue by Region
Table 122. PAREXEL International Corporation: Company Snapshot
Table 123. PAREXEL International Corporation: Business Segmentation
Table 124. PAREXEL International Corporation: Revenue by Region, 2018, %
Table 125. PAREXEL International Corporation: Product Portfolio
Table 126. Pfizer Inc.: Company Snapshot
Table 127. Pfizer Inc.: Business Segmentation
Table 128. Pfizer Inc.: Breakdown of Revenue by Product Category
Table 129. Pfizer Inc.: Breakdown of Revenue by Region
Table 130. Pfizer Inc.: Product Portfolio
Table 131. Pfizer Inc.: Revenue, 2018-2020, $ bn
Table 132. Pharmaceutical Product Development LLC (PPD): Company Snapshot
Table 133. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Division
Table 134. Pharmaceutical Product Development LLC (PPD): Breakdown of Revenue by Region
Table 135. Phlexglobal: Company Snapshot
Table 136. PRA Health Sciences Inc.: Company Snapshot
Table 137. PRA Health Sciences Inc.: Business Segmentation
Table 138. PRA Health Sciences Inc.: Revenue by Region, 2018, %
Table 139. Sanofi: Company Snapshot
Table 140. Sanofi: Business Segmentation
Table 141. Sanofi: Breakdown of Revenue by Region
Table 142. SGS SA (SGS Life Sciences): Company Snapshot
Table 143. SGS SA (SGS Life Sciences): Business Segmentation
Table 144. SGS SA (SGS Life Sciences): Revenue by Region, 2018, %
Table 145. Syneos Health Inc.: Company Snapshot
Table 146. Syneos Health Inc.: Business Segmentation
Table 147. Syneos Health Inc.: Revenue by Region, 2020, %
Table 148. WuXi AppTec Inc.: Company Snapshot
LIST OF FIGURES:
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2031
Figure 4. Global Clinical Trials Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Clinical Trials Market
Figure 7. Percentage of Trial Participants by Country, 2015-2019
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Global Clinical Trials Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of Global Clinical Trials Market
Figure 14. Breakdown of Global Clinical Trials Market by Product Category, 2021-2031, % of Revenue
Figure 15. Global Addressable Market Cap in 2023-2031 by Product Category, Value ($ mn) and Share (%)
Figure 16. Global Clinical Trials Market by Product Category: Trials of Drugs, 2021-2031, $ mn
Figure 17. Global Clinical Trials Market by Trials of Drugs: Small Molecule Drugs, 2021-2031, $ mn
Figure 18. Global Clinical Trials Market by Trials of Drugs: Vaccines, 2021-2031, $ mn
Figure 19. Global Clinical Trials Market by Trials of Drugs: Cell & Gene Therapy, 2021-2031, $ mn
Figure 20. Global Clinical Trials Market by Trials of Drugs: Other Drugs, 2021-2031, $ mn
Figure 21. Global Clinical Trials Market by Product Category: Trials of Devices, 2021-2031, $ mn
Figure 22. Global Clinical Trials Market by Product Category: Trials of Procedures, 2021-2031, $ mn
Figure 23. Breakdown of Global Clinical Trials Market by Phase, 2021-2031, % of Sales Revenue
Figure 24. Global Addressable Market Cap in 2023-2031 by Phase, Value ($ mn) and Share (%)
Figure 25. Global Clinical Trials Market by Phase: Phase I, 2021-2031, $ mn
Figure 26. Global Clinical Trials Market by Phase: Phase II, 2021-2031, $ mn
Figure 27. Global Clinical Trials Market by Phase: Phase III, 2021-2031, $ mn
Figure 28. Global Clinical Trials Market by Phase: Phase IV, 2021-2031, $ mn
Figure 29. Breakdown of Global Clinical Trials Market by Design, 2021-2031, % of Sales Revenue
Figure 30. Global Addressable Market Cap in 2023-2031 by Design, Value ($ mn) and Share (%)
Figure 31. Global Clinical Trials Market by Design: Interventional Studies, 2021-2031, $ mn
Figure 32. Global Clinical Trials Market by Interventional Studies: Randomized Control Trial, 2021-2031, $ mn
Figure 33. Global Clinical Trials Market by Interventional Studies: Adaptive Clinical Trial, 2021-2031, $ mn
Figure 34. Global Clinical Trials Market by Interventional Studies: Non-randomized Control Trial, 2021-2031, $ mn
Figure 35. Global Clinical Trials Market by Design: Observational Studies, 2021-2031, $ mn
Figure 36. Global Clinical Trials Market by Observational Studies: Cohort Study, 2021-2031, $ mn
Figure 37. Global Clinical Trials Market by Observational Studies: Case Control Study, 2021-2031, $ mn
Figure 38. Global Clinical Trials Market by Observational Studies: Cross Sectional Study, 2021-2031, $ mn
Figure 39. Global Clinical Trials Market by Observational Studies: Ecological Study, 2021-2031, $ mn
Figure 40. Global Clinical Trials Market by Design: Expanded Access Trials, 2021-2031, $ mn
Figure 41. Breakdown of Global Clinical Trials Market by Service Type, 2021-2031, % of Revenue
Figure 42. Global Addressable Market Cap in 2023-2031 by Service Type, Value ($ mn) and Share (%)
Figure 43. Global Clinical Trials Market by Service Type: Protocol Designing, 2021-2031, $ mn
Figure 44. Global Clinical Trials Market by Service Type: Site Identification, 2021-2031, $ mn
Figure 45. Global Clinical Trials Market by Service Type: Patient Recruitment, 2021-2031, $ mn
Figure 46. Global Clinical Trials Market by Service Type: Laboratory Services, 2021-2031, $ mn
Figure 47. Global Clinical Trials Market by Service Type: Bioanalytical Testing Services, 2021-2031, $ mn
Figure 48. Global Clinical Trials Market by Service Type: Clinical Trial Data Management Services, 2021-2031, $ mn
Figure 49. Global Clinical Trials Market by Service Type: Clinical Trial Supply & Logistic Services, 2021-2031, $ mn
Figure 50. Global Clinical Trials Market by Service Type: Decentralized Clinical Trial Services, 2021-2031, $ mn
Figure 51. Global Clinical Trials Market by Service Type: Medical Device Testing Services, 2021-2031, $ mn
Figure 52. Global Clinical Trials Market by Service Type: Other Clinical Trial Services, 2021-2031, $ mn
Figure 53. Breakdown of Global Clinical Trials Market by Indication, 2021-2031, % of Revenue
Figure 54. Global Addressable Market Cap in 2023-2031 by Indication, Value ($ mn) and Share (%)
Figure 55. Global Clinical Trials Market by Indication: Oncology, 2021-2031, $ mn
Figure 56. Global Clinical Trials Market by Indication: Infectious Diseases, 2021-2031, $ mn
Figure 57. Global Clinical Trials Market by Indication: Cardiology, 2021-2031, $ mn
Figure 58. Global Clinical Trials Market by Indication: Obesity, 2021-2031, $ mn
Figure 59. Global Clinical Trials Market by Indication: Diabetes, 2021-2031, $ mn
Figure 60. Global Clinical Trials Market by Indication: Neurology, 2021-2031, $ mn
Figure 61. Global Clinical Trials Market by Indication: Immunology, 2021-2031, $ mn
Figure 62. Global Clinical Trials Market by Indication: Pain Management, 2021-2031, $ mn
Figure 63. Global Clinical Trials Market by Indication: Other Indications, 2021-2031, $ mn
Figure 64. Breakdown of Global Clinical Trials Market by End User, 2021-2031, % of Revenue
Figure 65. Global Addressable Market Cap in 2023-2031 by End User, Value ($ mn) and Share (%)
Figure 66. Global Clinical Trials Market by End User: Pharmaceutical and Biotechnological Companies, 2021-2031, $ mn
Figure 67. Global Clinical Trials Market by End User: Clinical Research Organizations, 2021-2031, $ mn
Figure 68. Global Clinical Trials Market by End User: Clinical Testing Laboratories, 2021-2031, $ mn
Figure 69. Global Clinical Trials Market by End User: Other End Users, 2021-2031, $ mn
Figure 70. Global Market Snapshot by Region
Figure 71. Geographic Spread of Worldwide Clinical Trials Market, 2021-2031, % of Sales Revenue
Figure 72. Global Addressable Market Cap in 2023-2031 by Region, Value ($ mn) and Share (%)
Figure 73. North American Clinical Trials Market, 2021-2031, $ mn
Figure 74. Breakdown of North America Clinical Trials Market by Country, 2022 and 2031, % of Revenue
Figure 75. Contribution to North America 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 76. U.S. Clinical Trials Market, 2021-2031, $ mn
Figure 77. Canada Clinical Trials Market, 2021-2031, $ mn
Figure 78. Clinical Trials Market in Mexico, 2021-2031, $ mn
Figure 79. European Clinical Trials Market, 2021-2031, $ mn
Figure 80. Breakdown of European Clinical Trials Market by Country, 2022 and 2031, % of Revenue
Figure 81. Contribution to Europe 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 82. Clinical Trials Market in Germany, 2021-2031, $ mn
Figure 83. Clinical Trials Market in U.K., 2021-2031, $ mn
Figure 84. Clinical Trials Market in France, 2021-2031, $ mn
Figure 85. Clinical Trials Market in Spain, 2021-2031, $ mn
Figure 86. Clinical Trials Market in Italy, 2021-2031, $ mn
Figure 87. Clinical Trials Market in Russia, 2021-2031, $ mn
Figure 88. Clinical Trials Market in Rest of Europe, 2021-2031, $ mn
Figure 89. Asia-Pacific Clinical Trials Market, 2021-2031, $ mn
Figure 90. Breakdown of APAC Clinical Trials Market by Country, 2022 and 2031, % of Revenue
Figure 91. Contribution to APAC 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 92. Clinical Trials Market in Japan, 2021-2031, $ mn
Figure 93. Clinical Trials Market in China, 2021-2031, $ mn
Figure 94. Clinical Trials Market in Australia, 2021-2031, $ mn
Figure 95. Clinical Trials Market in India, 2021-2031, $ mn
Figure 96. Clinical Trials Market in South Korea, 2021-2031, $ mn
Figure 97. Clinical Trials Market in Rest of APAC, 2021-2031, $ mn
Figure 98. South America Clinical Trials Market, 2021-2031, $ mn
Figure 99. Breakdown of South America Clinical Trials Market by Country, 2022 and 2031, % of Revenue
Figure 100. Contribution to South America 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 101. Clinical Trials Market in Argentina, 2021-2031, $ mn
Figure 102. Clinical Trials Market in Brazil, 2021-2031, $ mn
Figure 103. Clinical Trials Market in Chile, 2021-2031, $ mn
Figure 104. Clinical Trials Market in Rest of South America, 2021-2031, $ mn
Figure 105. Clinical Trials Market in Middle East and Africa (MEA), 2021-2031, $ mn
Figure 106. Breakdown of MEA Clinical Trials Market by Country, 2022 and 2031, % of Revenue
Figure 107. Contribution to MEA 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 108. Clinical Trials Market in UAE, 2021-2031, $ mn
Figure 109. Clinical Trials Market in Saudi Arabia, 2021-2031, $ mn
Figure 110. Clinical Trials Market in South Africa, 2021-2031, $ mn
Figure 111. Growth Stage of Global Clinical Trials Industry over the Forecast Period
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2031
Figure 4. Global Clinical Trials Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Clinical Trials Market
Figure 7. Percentage of Trial Participants by Country, 2015-2019
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Global Clinical Trials Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of Global Clinical Trials Market
Figure 14. Breakdown of Global Clinical Trials Market by Product Category, 2021-2031, % of Revenue
Figure 15. Global Addressable Market Cap in 2023-2031 by Product Category, Value ($ mn) and Share (%)
Figure 16. Global Clinical Trials Market by Product Category: Trials of Drugs, 2021-2031, $ mn
Figure 17. Global Clinical Trials Market by Trials of Drugs: Small Molecule Drugs, 2021-2031, $ mn
Figure 18. Global Clinical Trials Market by Trials of Drugs: Vaccines, 2021-2031, $ mn
Figure 19. Global Clinical Trials Market by Trials of Drugs: Cell & Gene Therapy, 2021-2031, $ mn
Figure 20. Global Clinical Trials Market by Trials of Drugs: Other Drugs, 2021-2031, $ mn
Figure 21. Global Clinical Trials Market by Product Category: Trials of Devices, 2021-2031, $ mn
Figure 22. Global Clinical Trials Market by Product Category: Trials of Procedures, 2021-2031, $ mn
Figure 23. Breakdown of Global Clinical Trials Market by Phase, 2021-2031, % of Sales Revenue
Figure 24. Global Addressable Market Cap in 2023-2031 by Phase, Value ($ mn) and Share (%)
Figure 25. Global Clinical Trials Market by Phase: Phase I, 2021-2031, $ mn
Figure 26. Global Clinical Trials Market by Phase: Phase II, 2021-2031, $ mn
Figure 27. Global Clinical Trials Market by Phase: Phase III, 2021-2031, $ mn
Figure 28. Global Clinical Trials Market by Phase: Phase IV, 2021-2031, $ mn
Figure 29. Breakdown of Global Clinical Trials Market by Design, 2021-2031, % of Sales Revenue
Figure 30. Global Addressable Market Cap in 2023-2031 by Design, Value ($ mn) and Share (%)
Figure 31. Global Clinical Trials Market by Design: Interventional Studies, 2021-2031, $ mn
Figure 32. Global Clinical Trials Market by Interventional Studies: Randomized Control Trial, 2021-2031, $ mn
Figure 33. Global Clinical Trials Market by Interventional Studies: Adaptive Clinical Trial, 2021-2031, $ mn
Figure 34. Global Clinical Trials Market by Interventional Studies: Non-randomized Control Trial, 2021-2031, $ mn
Figure 35. Global Clinical Trials Market by Design: Observational Studies, 2021-2031, $ mn
Figure 36. Global Clinical Trials Market by Observational Studies: Cohort Study, 2021-2031, $ mn
Figure 37. Global Clinical Trials Market by Observational Studies: Case Control Study, 2021-2031, $ mn
Figure 38. Global Clinical Trials Market by Observational Studies: Cross Sectional Study, 2021-2031, $ mn
Figure 39. Global Clinical Trials Market by Observational Studies: Ecological Study, 2021-2031, $ mn
Figure 40. Global Clinical Trials Market by Design: Expanded Access Trials, 2021-2031, $ mn
Figure 41. Breakdown of Global Clinical Trials Market by Service Type, 2021-2031, % of Revenue
Figure 42. Global Addressable Market Cap in 2023-2031 by Service Type, Value ($ mn) and Share (%)
Figure 43. Global Clinical Trials Market by Service Type: Protocol Designing, 2021-2031, $ mn
Figure 44. Global Clinical Trials Market by Service Type: Site Identification, 2021-2031, $ mn
Figure 45. Global Clinical Trials Market by Service Type: Patient Recruitment, 2021-2031, $ mn
Figure 46. Global Clinical Trials Market by Service Type: Laboratory Services, 2021-2031, $ mn
Figure 47. Global Clinical Trials Market by Service Type: Bioanalytical Testing Services, 2021-2031, $ mn
Figure 48. Global Clinical Trials Market by Service Type: Clinical Trial Data Management Services, 2021-2031, $ mn
Figure 49. Global Clinical Trials Market by Service Type: Clinical Trial Supply & Logistic Services, 2021-2031, $ mn
Figure 50. Global Clinical Trials Market by Service Type: Decentralized Clinical Trial Services, 2021-2031, $ mn
Figure 51. Global Clinical Trials Market by Service Type: Medical Device Testing Services, 2021-2031, $ mn
Figure 52. Global Clinical Trials Market by Service Type: Other Clinical Trial Services, 2021-2031, $ mn
Figure 53. Breakdown of Global Clinical Trials Market by Indication, 2021-2031, % of Revenue
Figure 54. Global Addressable Market Cap in 2023-2031 by Indication, Value ($ mn) and Share (%)
Figure 55. Global Clinical Trials Market by Indication: Oncology, 2021-2031, $ mn
Figure 56. Global Clinical Trials Market by Indication: Infectious Diseases, 2021-2031, $ mn
Figure 57. Global Clinical Trials Market by Indication: Cardiology, 2021-2031, $ mn
Figure 58. Global Clinical Trials Market by Indication: Obesity, 2021-2031, $ mn
Figure 59. Global Clinical Trials Market by Indication: Diabetes, 2021-2031, $ mn
Figure 60. Global Clinical Trials Market by Indication: Neurology, 2021-2031, $ mn
Figure 61. Global Clinical Trials Market by Indication: Immunology, 2021-2031, $ mn
Figure 62. Global Clinical Trials Market by Indication: Pain Management, 2021-2031, $ mn
Figure 63. Global Clinical Trials Market by Indication: Other Indications, 2021-2031, $ mn
Figure 64. Breakdown of Global Clinical Trials Market by End User, 2021-2031, % of Revenue
Figure 65. Global Addressable Market Cap in 2023-2031 by End User, Value ($ mn) and Share (%)
Figure 66. Global Clinical Trials Market by End User: Pharmaceutical and Biotechnological Companies, 2021-2031, $ mn
Figure 67. Global Clinical Trials Market by End User: Clinical Research Organizations, 2021-2031, $ mn
Figure 68. Global Clinical Trials Market by End User: Clinical Testing Laboratories, 2021-2031, $ mn
Figure 69. Global Clinical Trials Market by End User: Other End Users, 2021-2031, $ mn
Figure 70. Global Market Snapshot by Region
Figure 71. Geographic Spread of Worldwide Clinical Trials Market, 2021-2031, % of Sales Revenue
Figure 72. Global Addressable Market Cap in 2023-2031 by Region, Value ($ mn) and Share (%)
Figure 73. North American Clinical Trials Market, 2021-2031, $ mn
Figure 74. Breakdown of North America Clinical Trials Market by Country, 2022 and 2031, % of Revenue
Figure 75. Contribution to North America 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 76. U.S. Clinical Trials Market, 2021-2031, $ mn
Figure 77. Canada Clinical Trials Market, 2021-2031, $ mn
Figure 78. Clinical Trials Market in Mexico, 2021-2031, $ mn
Figure 79. European Clinical Trials Market, 2021-2031, $ mn
Figure 80. Breakdown of European Clinical Trials Market by Country, 2022 and 2031, % of Revenue
Figure 81. Contribution to Europe 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 82. Clinical Trials Market in Germany, 2021-2031, $ mn
Figure 83. Clinical Trials Market in U.K., 2021-2031, $ mn
Figure 84. Clinical Trials Market in France, 2021-2031, $ mn
Figure 85. Clinical Trials Market in Spain, 2021-2031, $ mn
Figure 86. Clinical Trials Market in Italy, 2021-2031, $ mn
Figure 87. Clinical Trials Market in Russia, 2021-2031, $ mn
Figure 88. Clinical Trials Market in Rest of Europe, 2021-2031, $ mn
Figure 89. Asia-Pacific Clinical Trials Market, 2021-2031, $ mn
Figure 90. Breakdown of APAC Clinical Trials Market by Country, 2022 and 2031, % of Revenue
Figure 91. Contribution to APAC 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 92. Clinical Trials Market in Japan, 2021-2031, $ mn
Figure 93. Clinical Trials Market in China, 2021-2031, $ mn
Figure 94. Clinical Trials Market in Australia, 2021-2031, $ mn
Figure 95. Clinical Trials Market in India, 2021-2031, $ mn
Figure 96. Clinical Trials Market in South Korea, 2021-2031, $ mn
Figure 97. Clinical Trials Market in Rest of APAC, 2021-2031, $ mn
Figure 98. South America Clinical Trials Market, 2021-2031, $ mn
Figure 99. Breakdown of South America Clinical Trials Market by Country, 2022 and 2031, % of Revenue
Figure 100. Contribution to South America 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 101. Clinical Trials Market in Argentina, 2021-2031, $ mn
Figure 102. Clinical Trials Market in Brazil, 2021-2031, $ mn
Figure 103. Clinical Trials Market in Chile, 2021-2031, $ mn
Figure 104. Clinical Trials Market in Rest of South America, 2021-2031, $ mn
Figure 105. Clinical Trials Market in Middle East and Africa (MEA), 2021-2031, $ mn
Figure 106. Breakdown of MEA Clinical Trials Market by Country, 2022 and 2031, % of Revenue
Figure 107. Contribution to MEA 2023-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 108. Clinical Trials Market in UAE, 2021-2031, $ mn
Figure 109. Clinical Trials Market in Saudi Arabia, 2021-2031, $ mn
Figure 110. Clinical Trials Market in South Africa, 2021-2031, $ mn
Figure 111. Growth Stage of Global Clinical Trials Industry over the Forecast Period
